Clinical Trial Update: Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lipid changes and safety of raltegravir in HIV-infected patients with hyperlipidemia on current standard therapy. The study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: The Miriam Hospital | Conditions: HIV, Hyperlipidemia | Phase 3 | Status: COMPLETED | Results posted: 2014-10-10